Cel-Sci
CVM
$1.72
Share price
5.52%
Change (1 day)
-31.20%
Change (1 year)
Categories
Cel-Sci (CVM) - Cash on Hand
Cash on Hand as of December 2023 : $3.24 M
According to Cel-Sci
's latest financial reports the company has $3.24 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Cel-Sci - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-09-30 | $4.14 M | -81.71% |
| 2022-09-30 | $22.67 M | -46.29% |
| 2021-09-30 | $42.21 M | 172.18% |
| 2020-09-30 | $15.5 M | 83.65% |
| 2019-09-30 | $8.44 M | -18.09% |
| 2018-09-30 | $10.31 M | 335.13% |
| 2017-09-30 | $2.36 M | -18.8% |
| 2016-09-30 | $2.91 M | -49.05% |
| 2015-09-30 | $5.72 M | -32.74% |
| 2014-09-30 | $8.51 M | 20359.53% |
| 2013-09-30 | $0.04 M | -98.94% |
| 2012-09-30 | $3.94 M | -7.5% |
| 2011-09-30 | $4.26 M | -83.96% |
| 2010-09-30 | $26.56 M | -20.85% |
| 2009-09-30 | $33.56 M | 3583.65% |
| 2008-09-30 | $0.91 M | -91.71% |
| 2007-09-30 | $10.99 M | 36.05% |
| 2006-09-30 | $8.08 M | 312.77% |
| 2005-09-30 | $1.95 M | -54.09% |
| 2004-09-30 | $4.26 M | 143.18% |
| 2003-09-30 | $1.75 M | -15.68% |
| 2002-09-30 | $2.07 M | -12.54% |
| 2001-09-30 | $2.37 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 808,738.05% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 337,527.72% | 🇺🇸 USA |
 Xencor XNCR | $0.59 B | 18,216.70% | 🇺🇸 USA |
 Curis CRIS | $56.33 M | 1,637.93% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 99,423.67% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | $0.38 B | 11,900.44% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.11 B | 3,346.00% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $7.57 M | 133.69% | 🇺🇸 USA |